Literature DB >> 3755233

Cryotherapy for active retinopathy of prematurity.

W Tasman, G C Brown, D B Schaffer, G Quinn, M Naidoff, W E Benson, G Diamond.   

Abstract

Twenty-eight patients with bilateral symmetrical Stage 3 retinopathy of prematurity (ROP) and plus disease had one eye assigned to cryotherapy and the other to control. The majority of patients weighed under 1000 grams at birth and females outnumbered males by nearly a two-to-one ratio.+ Cryotherapy was generally performed at a gestational age of less than 40 weeks and a mean chronologic age of 10 weeks. Eleven patients showed improvement in both the treated and untreated eyes possibly due to variables among prematures not identified in the study. Eleven other patients experienced improvement in the treated eye and progression in the untreated eye. Using the binomial distribution on the latter group the P value was 0.0005 with a one-tailed hypothesis test and 0.001 with a two-tailed test, suggesting that in the sampled population cryotherapy appears to be preferred over no treatment.

Entities:  

Mesh:

Year:  1986        PMID: 3755233     DOI: 10.1016/s0161-6420(86)33680-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Incidence, severity and time course of ROP in a randomized clinical trial of vitamin E prophylaxis.

Authors:  G E Quinn; L Johnson; C Otis; D B Schaffer; F W Bowen
Journal:  Doc Ophthalmol       Date:  1990-03       Impact factor: 2.379

2.  Effect of partial cryoablation on retinopathy of prematurity.

Authors:  I Nissenkorn; R Axer-Siegel; I Kremer; I Ben-Sira
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

3.  Surgical therapy for stage V retinopathy of prematurity. A two-step approach.

Authors:  M T Trese
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

4.  Late visual field changes following cryotherapy for retinopathy of prematurity stage 3.

Authors:  I Kremer; I Nissenkorn; M Lusky; Y Yassur
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

5.  Diode laser photocoagulation for retinopathy of prematurity.

Authors:  T Tsitsis; W Tasman; J A McNamara; G Brown; J Vander
Journal:  Trans Am Ophthalmol Soc       Date:  1997

6.  Comparison of Intravitreal Anti-VEGF Agents With Laser Photocoagulation for Retinopathy of Prematurity of 1,627 Eyes in China.

Authors:  Dandan Linghu; Yong Cheng; Xuemei Zhu; Xun Deng; Hong Yin; Yanrong Jiang; Mingwei Zhao; Xiaoxin Li; Jianhong Liang
Journal:  Front Med (Lausanne)       Date:  2022-05-31

Review 7.  Translational Research in Retinopathy of Prematurity: From Bedside to Bench and Back Again.

Authors:  Mitsuru Arima; Yuya Fujii; Koh-Hei Sonoda
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.